This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Harvard College, Zikani Therapeutics, Inc.. Active years: 2026.
Company Filing History:
1 out of 3,071 
1 out of 1 Years Active: 2026
Title: Ivan Jewett: Innovator in Macrolide Research
Introduction
Ivan Jewett is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of macrolide antibiotics. His work focuses on innovative solutions for treating infectious diseases.
Latest Patents
Ivan Jewett holds a patent for "C10-alkylene substituted 13-membered macrolides and uses thereof." This patent describes 13-membered macrolides that are specifically designed for the treatment of infectious diseases. The macrolides detailed in his patent are azaketolides, which are effective against Gram-negative bacteria. The patent also outlines methods for preparing these macrolides, pharmaceutical compositions that include them, and their application in treating various infections.
Career Highlights
Throughout his career, Ivan Jewett has worked with prestigious institutions, including Harvard College and Zikani Therapeutics, Inc. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Ivan has collaborated with notable professionals in his field, including Roger B. Clark and Wesley Francis Austin. These partnerships have enriched his research and expanded the impact of his work.
Conclusion
Ivan Jewett's innovative research in macrolide antibiotics showcases his commitment to addressing critical health challenges. His contributions are vital in the ongoing fight against infectious diseases.